Lyft, a privately held American transportation network company and Uber Technologies’ biggest rival in the U.S., hopes to reach the $1 billion mark in gross annual revenue, the company's co-founder John Zimmer told Reuters.
The $1 billion figure was based on its gross bookings in October, when it made around $83 million off of 7 million rides, excluding Halloween.
"It demonstrates what a large business opportunity this is," said Zimmer. "The market that we are playing in is ... a $2.25 trillion transportation industry."
The San Francisco-based company has over 40 percent market share in San Francisco and in Austin, Texas. It has raised $1 billion at a $2.5 billion valuation, and Zimmer added it still has "the far, far majority of that money in the bank," without revealing any details.
The company partnered with the world's largest one-stop mobile transportation platform, Didi Kuaidi in September. As part of the alliance, Didi has invested $100 million in Lyft, in a financing round led by Rakuten earlier this year that also included Carl Icahn, Alibaba and Tencent.
According to the New York Times, the company is seeking approximately $500 million at a valuation of about $4 billion, significantly up from current valuation of about $2.5 billion. However, the figures may change as fund-raising talks continue, people familiar with the matter told the publication house.


Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Street Poller Media and The Boom of the Street Interview Ad Industry
Google Changes EU Spam Policy Amid Antitrust Scrutiny
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
Amazon Secures 200 MW Wind Power Deals in Sweden
OpenAI AI Agent Swarm Behind Hugging Face Hack
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 



